Dobutamine

Dobutamine

Form: Intravenous (IV) Injection

Strength: 12.5 mg/mL

Reference Brands: Dobutrex(US), Dobutamina Hameln, Dobutamine Accord, Dobutamine Fresenius Kabi(EU)

Category: Critical Care

Dobutamine is a fast-acting inotropic agent used to treat acute heart failure and cardiogenic shock by enhancing cardiac output. Administered via intravenous infusion, it acts on beta-1 adrenergic receptors to improve myocardial contractility. Dobutamine is commonly available in 12.5 mg/mL concentration, supplied in 250 mg/20 mL and 500 mg/40 mL vials or ready-to-use infusion bags. Brands like Dobutamina Hameln and Dobutamine Fresenius are well-recognized in the EU, with various generics available in the US. Dobutamine is a critical care medication procured by hospitals, ICUs, and emergency departments, often listed in institutional tenders and group purchasing organizations.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Glucagon

Strength: 1 mg lyophilized powder for reconstitution (IM/SC/IV)

Form: Intramuscular (IM), Subcutaneous (SC), and Intravenous (IV) injection

Reference Brands: Glucagen®, Gvoke®,Baqsimi®(US); Glucagen® Hypokit(EU)

View Details Get Enquiry
Insulin (IV)

Strength: 100 units/mL (U-100) in 10 mL vials

Form: Intravenous (IV) solution

Reference Brands: Humulin® R, Novolin® R(US); Actrapid®, Humulin® R, Insuman® Rapid(EU)

View Details Get Enquiry
Flumazenil

Strength: 0.1 mg/mL in 5 mL or 10 mL vials

Form: Intravenous (IV) injection

Reference Brands: Romazicon®(US), Anexate®(EU)

View Details Get Enquiry
Naloxone

Strength: 0.4 mg/mL in 1 mL/10 mL vials, 1 mg/mL in 2 mL prefilled syringes

Form: Intravenous (IV) injection/IM/SQ

Reference Brands: Narcan® (US); Narcan® (EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.